To further validate CD44+/CD24− as a putative CSC population in EC, we studied the protein expression of the pluripotent stem cell marker SOX2 in OE33 and OE21 cells, which derived from EAC and ESCC, respectively. The gene discussed is CD44; the disease is esophageal squamous cell carcinoma.